Cite
MLA Citation
Kei Sakamoto et al.. “BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides.” Journal of clinical pharmacology, vol. 57, 2017, pp. 1460–1471. http://access.bl.uk/ark:/81055/vdc_100050560393.0x000053